Latest Updates

The expansion will include the production of commercial quantities of a second Bristol-Myers Squibb biologic medicine

Efforts to control the epidemic are dangerously out of step with international recommendations and proven best practices, leaving…

Net profit for the second quarter increases by seven per cent to Rs 1650.78 m

After-tax profits in the second quarter of FY 2015 were $0.83 million

Expiry of blockbuster Rituxan in the EU will hinder its market growth there

The Supervisory Board of BASF has appointed Sanjeev Gandhi to the Board of Executive Directors effective December 1, 2014

To submit its first ebola treatment data to the FDA soon

$3 billion global market has been growing annually at double-digit rates

Acquires minority stake

Event to be held in Gandhinagar on December 6, 2014